Navigation Links
Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Date:2/7/2011

essionals and public health officials. You may learn more about CDI at www.cdiinfo.org, a website of Optimer.

About AstellasAstellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation is committed to becoming a global company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21 affiliate offices located across Europe, the Middle East and Africa, an R&D site and three manufacturing plants. The company employs approximately 3,900 staff across these regions.  For more information about Astellas Pharma Europe, please visit www.astellas.eu.

About Optimer PharmaceuticalsOptimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing hospital specialty products to treat serious infections and address unmet medical needs. Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ (prulifloxacin). Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection. The FDA granted Optimer's request for a six-month Priority Review of fidaxomicin, and has assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 30, 2011. Optimer has also filed a MAA with the European Medicines Agency (EMA) for fidaxomicin. Pruvel™ is a prodrug in the fluoroquinolone class of antibiotics being developed as a treatment for infectious diarrhea. Additional information can be found at http://www.optimerpharma.com.

Forward-looking Statements Stateme
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... 24, 2015 Research and Markets ( ... "Global Biobanking Market 2015-2019" report to their offering. ... to grow at a CAGR of 7.07% over the ... be divided into two segments: Equipment and Consumables. This ... of the Global Biobanking market for the period 2015-2019. ...
(Date:4/24/2015)... -- Introduction of new "Elements" ... for radiosurgery/SBRT   The "Elements" strategy ... the workflow for difficult to treat indications in ... comes full circle with the introduction of automated ... enable on-the-fly generation of consistent treatment plans for ...
(Date:4/24/2015)... April 24, 2015 The National Institute ... the National Institutes of Health [NIH])  provided grants ... projects for the development of diagnostic tests for ... outbreaks at U.S. health facilities , the NIAID ... rapid, multiplexed and effective tests using alternative methods ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
(Date:4/25/2015)... 2015 Gardant Management Solutions will ... and operations, and sales and marketing at the ... to be held from April 29 through May ... the largest eldercare association in Illinois. The statewide ... older adults, including senior housing, assisted living and ...
(Date:4/25/2015)... OR (PRWEB) April 25, 2015 Sports controversies continue ... within team confines, as was the case with the Miami Dolphins ... team as seen in the Ray Rice domestic abuse case. In ... of Sporting News discusses the implications of locker room culture ... response and what other teams should do to improve the locker ...
(Date:4/24/2015)... Bird B Gone, the leader in bird ... a complete line of bird control solutions to address the ... Flu Strains Threaten Pacific, Central and Mississippi Farms , According ... a number of highly pathogenic avian flus in the Pacific, ... spread when wild birds enter poultry farms. The USDA urges ...
(Date:4/24/2015)... 24, 2015 As the nation recognizes ... unique sacrifices of these young men and women, the ... Veterans and their Families” presents a special training session ... to gain a better understanding of the effect of ... For those – civilian and military – who provide ...
(Date:4/24/2015)... 2015 The Fastest Fat Loss Week Ever, ... success of the Xtreme Fat Loss Diet, has been causing ... loss blueprint that claims to help one lose belly fat ... Stan Stevenson, prompting an investigative review. , "Our Fastest ... spent years researching and experimenting with these methods on their ...
Breaking Medicine News(10 mins):Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2
... The Central government of India plans to come out ... of technologies discovery by Indian universities //and research institutions ... ,The proposed legislation would give Indian universities and institutions ... CSIR the ability to stake claims on discoveries they ...
... more than $10 billion. The drug is prescribed ... of cardiovascular// disease and diabetes and those with ... conducting raids at some wholesale locations British authorities ... Lipitor . Officials are also contacting 20,000 pharmacy ...
... Researchers have discovered the protein that enables the malaria ... findings, which were published in the journal Cell, will ... disease of malaria.// ,A major pathway through which ... of a protein on the surface of merozoites called ...
... Cocoa compounds have various uses , it can be marketed ... pharmaceuticals.// ,Researchers now say they have been able ... and now have an impressive library of different flavonols. They ... those found in nature but also compounds tailored to specific ...
... be keeping patients on urinary catheters longer than necessary, ... infections, said a new study published in the Joint ... says that a simple reminder note put by the ... ,Research showed that about 25 percent of hospital ...
... extend the lifespan of many species through Sir2 gene.//, ... University of California, Davis, screened for genes that could ... study published today in the advance online edition of ... not live longer when subjected to calorie restriction, suggesting ...
Cached Medicine News:Health News:Researchers Discover Protein That Causes Malaria 2Health News:Patients Are Given Catheter Longer Than Necessary 2Health News:Genes to Extend Longevity Discovered 2
... developed in surgeon's desire to have the ... instrument with the strength to maneuver into ... bending or breaking. Arthrotek Hand Instruments are ... the surgeon's hand. This new generation of ...
... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
Medicine Products: